Table 1.
Clinical variables of patients at entry to the study
| ESO (n = 50) | LAN (n = 50) | |
|---|---|---|
| Age (yr, s.e.m.)* |
65.0 (2.2) |
62.7 (2.3) |
| Sex (%) |
|
|
| Male |
37 (74%) |
34 (68%) |
| Female |
13 (26%) |
16 (32%) |
| Locations of ulcer (%) |
|
|
| Stomach |
22 (44%) |
18 (32%) |
| Duodenum |
28 (56%) |
32 (68%) |
| Endoscopic findings (%) |
|
|
| Spurting |
6(12%) |
4 (8%) |
| Oozing |
15 (30%) |
18 (36%) |
| NBVV |
29 (58%) |
28 (56%) |
| Gastric contents (%) |
|
|
| Blood |
14 (28%) |
9 (18%) |
| Coffee grounds |
22 (44%) |
20 (40%) |
| Clear |
14 (28%) |
21 (42%) |
| Shock (%) |
21 (42%) |
18 (36%) |
| Medical comorbidity (%) |
33 (66%) |
30 (60%) |
| Ulcer size (cm, s.e.m.) |
1.4 (0.2) |
1.6 (0.2) |
|
H. pylori infection (%) |
26 (68.4%) |
25 (68.6%) |
| Hemoglobin (g/dl, s.e.m.) |
9.6(0.34) |
10.7(0.38) |
| Rockall score (mean, s.e.m.) | 5.3 (0.2) | 5.3 (0.3) |
*Numerical variables expressed as mean and standard error of mean (s.e.m.)
There were no statistically significant differences between the two groups.